It has also been postulated as a potential therapeutic agent against the neurodegeneration characteristic of Alzheimer’s disease (AD), where it reduces the accumulation of amyloid β-peptide and the hyperphosphorylation of the tau protein in cellular models of AD [9]. The gene discussed is MAPT; the disease is Alzheimer disease.